| Sabrina Elizabeth Von Bargen, DDS | |
|
4830 Chateau Ave, North Charleston, SC 29405 | |
| (843) 225-8718 | |
| Not Available |
| Full Name | Sabrina Elizabeth Von Bargen |
|---|---|
| Gender | Female |
| Speciality | Dentist - General Practice |
| Location | 4830 Chateau Ave, North Charleston, South Carolina |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1891355079 | NPI | - | NPPES |
| Mailing Address | Practice Location Address |
|---|---|
| Sabrina Elizabeth Von Bargen, DDS 4830 Chateau Ave, North Charleston, SC 29405 Ph: (843) 225-8718 | Sabrina Elizabeth Von Bargen, DDS 4830 Chateau Ave, North Charleston, SC 29405 Ph: (843) 225-8718 |
News Archive
Ahura Scientific, Inc., the leader in field-deployed analytical instruments for human health and public safety, today announced two milestones: it has reached $100 million in product revenue since its first product shipment in 2005 and the company now serves more than 100 pharmaceutical facilities within two years of introducing its TruScan device to the market.
University of Adelaide research into the origins of ovarian cancer has led to the discovery of a genetic pathway that could slow the spread of the cancer.
The role of microRNAs is fundamental for the correct moment-to-moment adjustment in the expression of target genes. "Before this study, we already knew that these small molecules could be packaged into small vesicles and exported to the extracellular space, to be later captured by other cells and in this way play an important role in intercellular communication," explains CNIC researcher Carolina Villarroya, the first author on the study.
Anavex Life Sciences Corp. today announced screening of the first healthy volunteers for the Phase I clinical study of ANAVEX 2-73, its lead compound for the treatment of Alzheimer's disease. ANAVEX 2-73 is the first of a new class of wholly-owned, oral, disease-modifying compounds, which act through sigma-1 receptor agonist as well as muscarinic cholinergic effects and up-regulation of Bcl-2.
Baxalta Incorporated, a global biopharmaceutical leader dedicated to delivering transformative therapies to patients with orphan diseases and underserved conditions, today announced initial results from a Phase 3 clinical trial of ADYNOVATE [Antihemophilic Factor (Recombinant), PEGylated], an extended circulating half-life recombinant Factor VIII (rFVIII) treatment for hemophilia A based on ADVATE [Antihemophilic Factor (Recombinant)].
› Verified 2 days ago
Dr. Christopher Poston Rivers, D.M.D. Dentist Medicare: Not Enrolled in Medicare Practice Location: 8310 Rivers Ave Ste D, North Charleston, SC 29406 Phone: 843-797-7200 Fax: 843-797-8293 | |
Amber Houston Connar, DMD Dentist Medicare: Medicare Enrolled Practice Location: 6035 Rivers Ave Ste A, North Charleston, SC 29406 Phone: 843-572-9909 Fax: 843-572-9901 | |
Dr. Frederick Madison Gunter, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 7465 Northside Dr, North Charleston, SC 29420 Phone: 843-553-7300 Fax: 843-797-7631 | |
Patricia M Nicklas, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 6035 Rivers Ave Ste A, North Charleston, SC 29406 Phone: 843-572-9909 | |
Dr. Casey Mitchell Bennett, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 6335 Dorchester Rd, North Charleston, SC 29418 Phone: 843-552-2580 | |
Dr. James Eric Layton, DMD, MBA Dentist Medicare: Not Enrolled in Medicare Practice Location: 6335 Dorchester Rd, North Charleston, SC 29418 Phone: 843-552-2580 Fax: 843-552-2596 | |
George A Deussing, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 7465 Northside Dr, North Charleston, SC 29420 Phone: 843-797-5400 Fax: 843-797-5164 |